Concepedia

Catherine H. Gill

CH

14

Publications

1.2K

Citations

14

H-Index

1995

Active since

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

University of Glasgow

New Frontier

Molecular Discovery (United Kingdom)

University of Edinburgh

Catherine H. Gill is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, neuroscience, and neurophysiology.

Top concepts

Publications per year

1995–2011

14

Publications

14

Epileptogenesis and Enhanced Prepulse Inhibition in GABAB1-Deficient Mice

Haydn M. Prosser, Catherine H. Gill, Warren D. Hirst et al. · Molecular and Cellular Neuroscience · 2001 · 279 citations

, , +3

Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist

Martin J. Gunthorpe, Harshad K. Rami, Jeffrey C. Jerman et al. · Neuropharmacology · 2003 · 272 citations

, , +6

SB-334867-A antagonises orexin mediated excitation in the locus coeruleus

Ellen M. Soffin, Michael L. Evans, Catherine H. Gill et al. · Neuropharmacology · 2002 · 87 citations

, ,

An electrophysiological investigation of the properties of a murine recombinant 5‐HT<sub>3</sub> receptor stably expressed in HEK 293 cells

Catherine H. Gill, John A. Peters, Jeremy J. Lambert · British Journal of Pharmacology · 1995 · 79 citations · Full text

Characterisation of 5‐HT<sub>3C</sub>, 5‐HT<sub>3D</sub>and 5‐HT<sub>3E</sub>receptor subunits: evolution, distribution and function

Joanna D. Holbrook, Catherine H. Gill, Noureddine Zebda et al. · Journal of Neurochemistry · 2008 · 79 citations

Rows per page

1–5 of 14